Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Frontiers in Cardiovascular Medicine|April 4, 2022
Right Ventricular Function Improves Early After Percutaneous Mitral Valve Repair in Patients Suffering From Severe Mitral RegurgitationJonas Neuser, Hans Julian Buck, Maximiliane Oldhafer, et al.Circulation|August 6, 2008
Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarctionDaniela Fraccarollo, Julian D Widder, Paolo Galuppo, et al.European Heart Journal|October 8, 2010
Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humansThomas Thum, Kerstin Schmitter, Felix Fleissner, et al.Circulation|May 29, 2008
Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 exportCornelius F H Mueller, Kerstin Wassmann, Julian D Widder, et al.Diabetes|June 5, 2010
Increased cytochrome P4502E1 expression and altered hydroxyeicosatetraenoic acid formation mediate diabetic vascular dysfunction: rescue by guanylyl-cyclase activationAndreas Schäfer, Paolo Galuppo, Daniela Fraccarollo, et al.Journal of the American College of Cardiology|June 11, 2013
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in EuropeFrancesco Maisano, Olaf Franzen, Stephan Baldus, et al.Free Radical Biology & Medicine|August 10, 2006
Early determinants of H2O2-induced endothelial dysfunctionBeth M Boulden, Julian D Widder, Jon C Allen, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 13, 2016
Gender in the ACCESS-EU registry: a prospective, multicentre, non-randomised post-market approval study of MitraClip® therapy in EuropeSameer Gafoor, Horst Sievert, Francesco Maisano, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 3, 2007
Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin IIJulian D Widder, Tomasz J Guzik, Cornelius F H Mueller, et al.International Journal of Cardiology|June 19, 2015
Blood-based microRNA signatures differentiate various forms of cardiac hypertrophyAnselm A Derda, Sabrina Thum, Johan M Lorenzen, et al.Pageof 3